Breast cancer is the disease occurs when uncontrolled growth of malignant cells in the breast. Treatment of breast cancer depends on various factors such as the type of breast cancer, the size of a tumor, the stage of breast cancer and the grade of cancer cells. The breast cancer may be treated by various therapies such as radiation therapy, chemotherapy, hormone therapy, targeted therapy and bone-directed therapy. The common signs and symptoms associated with breast cancer include change in the breast shape, forming of lumps in the breast, dimpling of skin, and red scaly patches on the skin. In severe conditions, bone pain, swelling of lymph nodes, respiratory problems, and yellow skin may appear. The breast cancer is due to drinking alcohol, being female, obesity, ionizing radiation, family history and older age among others. The breast cancer is diagnosed by taking a biopsy of lump. After the diagnosis, further tests are carried out to determine the cancer stage and suitable treatment for the disease.
CAGR due to increased prevalence and incidence of breast cancer cases. Rising awareness about breast cancer treatment and treatment processes. Moreover, the increase in the health care expenditure, the increase in the consumption of alcohol and tobacco, and the rise of the breast cancer forecast period. Furthermore, increase in investments in research and development, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology.
A sample of this report is available upon request @
The breast cancer treatment market is segmented based on the treatment mechanism, treatment type, and distribution channel
Based on treatment mechanism, the breast cancer treatment market has been segmented into the following:
- Local
- adjuvant
- neoadjuvant
- Systemic
Based on drug class, the breast cancer treatment market has been segmented into the following:
- chemotherapy
- anthracyclines
- Antimetabolites
- epothilones
- taxanes
- Alkylating agents
- Hormonal therapy
- Aromatase inhibitors
- Selective estrogen receptor modulators
Based on the distribution channel, the breast cancer treatment market has been segmented into the following:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
To view TOC of this report is available upon request @
Global breast cancer treatment market is in the developing stage, owing to increase in the prevalence rate of breast cancer. According to World Health Organization, about 2000,000 new cases are diagnosed. The breast cancer treatment market focuses on research and development activities, strategic collaborations, acquisitions & mergers, and product launches for the development of their breast cancer treatment market. For instance, in March 2017, Novartis has received FDA approval for its kisqali (ribociclib, LEE011) drug as a first-line treatment for the HR + / HER2 metastatic breast cancer along with aromatase inhibitor. Similarly, in September 2013, The US Food and Drug Administration granted the accelerated approval for Perjeta (pertuzumab) used in the treatment of early stage breast cancer treatment before surgery. The innovation of some innovative therapy with better success rate.
Need more information about this report @
AstraZeneca (UK), GlaxoSmithKline plc (UK), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France) , Pfizer, Inc. (US). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (US), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (US), and OncoGenex Pharmaceuticals Inc. (US) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients make business decisions.
Precision Business Insights is a company that provides agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): 1-866-598-1553